{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:52:42Z","timestamp":1789498362626,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Early phase clinical trials continue to have difficulty with enrolling real-world populations with many minorities being underrepresented. Reasons for this include patient or clinician perception as well as cultural, linguistic, or social barriers. In Australia, there is currently no prospective data in the early phase clinical trial space regarding recruitment of priority populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patient Diversity in Early Phase Clinical Trials was a multicenter, prospective, cohort study involving 2 major early phase clinical trial centers in Sydney, Australia. All participants who were consented to an early phase clinical trial between August 2023 and August 2024 were enrolled. Participants completed a baseline demographic survey, which included cultural and linguistic status, sexual orientation, socioeconomic status, and regional diversity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 114 participants were recruited. Median age was 63\u2009years (range = 25-83\u2009years) with predominance for female participants (52%). No participant reported a nonbinary gender. All participants reported their sexuality as heterosexual, with no LGBTQIA+ participants recruited. A total of 34 (30%) participants were identified as culturally diverse, while 28 (25%) were linguistically diverse. One patient identified as Indigenous Australian. Of the participants, 26% were born overseas, with 44% having at least 1 parent born overseas. The majority were living in households with family members, with 8% of participants living alone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patient Diversity in Early Phase Clinical Trials is the first prospective study that provides granular description of social, cultural, linguistic, economic, and sexual diversity among early phase clinical trial participants. Certain subgroups are underrepresented, including those with sexual diversity, gender diversity, and Indigenous backgrounds. Ongoing efforts to monitor and promote inclusion of diverse populations in clinical trials are vital.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jncics\/pkaf035","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:51:39Z","timestamp":1743393099000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-9502","authenticated-orcid":false,"given":"Udit","family":"Nindra","sequence":"first","affiliation":[{"name":"Department of Medicine, Western Sydney University , Campbelltown,","place":["Australia"]},{"name":"Department of Medical Oncology, Wollongong Hospital , Wollongong,","place":["Australia"]},{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7530-9953","authenticated-orcid":false,"given":"Joanne","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-7471","authenticated-orcid":false,"given":"Jun Hee","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-4261","authenticated-orcid":false,"given":"Martin","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3716-8611","authenticated-orcid":false,"given":"Christina","family":"Teng","sequence":"additional","affiliation":[{"name":"Scientia Clinical Research , Randwick,","place":["Australia"]},{"name":"Department of Medical Oncology, Prince of Wales Hospital , Randwick,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-1079","authenticated-orcid":false,"given":"Joe","family":"Wei","sequence":"additional","affiliation":[{"name":"Scientia Clinical Research , Randwick,","place":["Australia"]},{"name":"Department of Medical Oncology, Prince of Wales Hospital , Randwick,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Killen","sequence":"additional","affiliation":[{"name":"Scientia Clinical Research , Randwick,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-1857","authenticated-orcid":false,"given":"Weng","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medicine, Western Sydney University , Campbelltown,","place":["Australia"]},{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-9431","authenticated-orcid":false,"given":"Charlotte","family":"Lemech","sequence":"additional","affiliation":[{"name":"Scientia Clinical Research , Randwick,","place":["Australia"]},{"name":"Department of Medical Oncology, Prince of Wales Hospital , Randwick,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Medicine, Western Sydney University , Campbelltown,","place":["Australia"]},{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-6569","authenticated-orcid":false,"given":"Abhijit","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liverpool Hospital , Liverpool,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"2025042412212670400_pkaf035-B1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(22)01390-3","article-title":"Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials","volume":"400","author":"Chihara","year":"2022","journal-title":"Lancet"},{"key":"2025042412212670400_pkaf035-B2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1200\/JCO.22.00754","article-title":"Increasing racial and ethnic diversity in cancer clinical trials: an American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement","volume":"40","author":"Oyer","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025042412212670400_pkaf035-B3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/OP.23.00291","article-title":"Improving access to cancer clinical trials for patients from culturally and linguistically diverse backgrounds in Australia: a survey of clinical and research professionals","volume":"19","author":"Pal","year":"2023","journal-title":"J Clin Oncol Oncol Pract"},{"key":"2025042412212670400_pkaf035-B4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13063-016-1384-3","article-title":"A review of approaches to improve participation of culturally and linguistically diverse populations in clinical trials","volume":"17","author":"Hughson","year":"2016","journal-title":"Trials"},{"key":"2025042412212670400_pkaf035-B5","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.3390\/ijerph182211801","article-title":"Health inequities in LGBT people and nursing interventions to reduce them: a systematic review","volume":"18","author":"Medina-Mart\u00ednez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025042412212670400_pkaf035-B6","doi-asserted-by":"crossref","first-page":"e2133205","DOI":"10.1001\/jamanetworkopen.2021.33205","article-title":"Racial and ethnic disparities among participants in precision oncology clinical studies","volume":"4","author":"Aldrighetti","year":"2021","journal-title":"JAMA Network Open"},{"key":"2025042412212670400_pkaf035-B7","first-page":"100252","article-title":"Race\/ethnicity reporting and representation in US clinical trials: A cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2025042412212670400_pkaf035-B8","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkae085","article-title":"Mediators of racial\/ethnic inequities in clinical trial participation among patients with cancer, 2011-2023","volume":"8","author":"Guadamuz","year":"2024","journal-title":"JNCI Cancer Spectr"},{"key":"2025042412212670400_pkaf035-B9","author":"Bygrave","year":"2020"},{"key":"2025042412212670400_pkaf035-B10","author":"ABo Statistics"},{"key":"2025042412212670400_pkaf035-B11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/00050067.2023.2299667","article-title":"Wellbeing programs for culturally and linguistically diverse population in Australia: barriers and improvements","volume":"59","author":"Kara","year":"2024","journal-title":"Austr Psychol"},{"key":"2025042412212670400_pkaf035-B12","author":"De Vaus","year":"2009"},{"key":"2025042412212670400_pkaf035-B13","first-page":"1","article-title":"Immune-based cancer treatment: addressing disparities in access and outcomes","volume":"41","author":"Osarogiagbon","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2025042412212670400_pkaf035-B14","first-page":"219","article-title":"Social characteristics of culturally and linguistically diverse cancer patients enrolled in early phase clinical trials in South-Western Sydney","volume":"103","author":"Childs","year":"2025","journal-title":"Oncology"},{"key":"2025042412212670400_pkaf035-B15","doi-asserted-by":"crossref","first-page":"103373","DOI":"10.1016\/j.esmoop.2024.103373","article-title":"Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers","volume":"9","author":"Vidal","year":"2024","journal-title":"ESMO Open"},{"key":"2025042412212670400_pkaf035-B16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ajco.12818","article-title":"Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers","volume":"14","author":"Smith","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"2025042412212670400_pkaf035-B17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1478-4491-11-69","article-title":"Foreign-born health workers in Australia: an analysis of census data","volume":"11","author":"Negin","year":"2013","journal-title":"Hum Resour Health"},{"key":"2025042412212670400_pkaf035-B18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1200\/OP.21.00001","article-title":"Participation of Black Americans in cancer clinical trials: current challenges and proposed solutions","volume":"17","author":"Awidi","year":"2021","journal-title":"J Clin Oncol Oncol Pract"},{"key":"2025042412212670400_pkaf035-B19","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1038\/s41598-023-35216-2","article-title":"Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database","volume":"13","author":"Gupta","year":"2023","journal-title":"Sci Rep"},{"key":"2025042412212670400_pkaf035-B20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1370\/afm.2901","article-title":"Recruiting indigenous patients into clinical trials: a circle of trust","volume":"21","author":"Mainous","year":"2023","journal-title":"Ann Fam Med"},{"key":"2025042412212670400_pkaf035-B21","doi-asserted-by":"crossref","first-page":"e001999","DOI":"10.1136\/bmjgh-2019-001999","article-title":"Trust, culture and communication: Determinants of eye health and care among Indigenous people with diabetes in Australia","volume":"5","author":"Yashadhana","year":"2020","journal-title":"BMJ Global Health"},{"key":"2025042412212670400_pkaf035-B22","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.5001\/omj.2020.40","article-title":"Implications of language barriers for healthcare: a systematic review","volume":"35","author":"Al Shamsi","year":"2020","journal-title":"Oman Med J"},{"key":"2025042412212670400_pkaf035-B23","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1017\/cts.2020.539","article-title":"Opening doors to clinical trial participation among Hispanics: lessons learned from the Spanish translation of ResearchMatch","volume":"5","author":"Byrne","year":"2020","journal-title":"J Clin Transl Sci"},{"key":"2025042412212670400_pkaf035-B24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s13104-020-05383-w","article-title":"What is the size of Australia\u2019s sexual minority population?","volume":"13","author":"Wilson","year":"2020","journal-title":"BMC Res Notes"},{"key":"2025042412212670400_pkaf035-B25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/10775595231226331","article-title":"Prevalence of diverse genders and sexualities in Australia and associations with five forms of child maltreatment and multi-type maltreatment","volume":"30","author":"Higgins","year":"2025","journal-title":"Child Maltreat"},{"key":"2025042412212670400_pkaf035-B26","doi-asserted-by":"crossref","first-page":"100608","DOI":"10.1016\/j.ssmph.2020.100608","article-title":"Healthcare avoidance due to anticipated discrimination among transgender people: a call to create trans-affirmative environments","volume":"11","author":"Kcomt","year":"2020","journal-title":"SSM Popul Health"},{"key":"2025042412212670400_pkaf035-B27","doi-asserted-by":"crossref","first-page":"107243","DOI":"10.1016\/j.cct.2023.107243","article-title":"Improving access for and experience of transgender and non-binary patients in clinical research: Insights from a transgender patient focus group and targeted literature reviews","volume":"131","author":"Round","year":"2023","journal-title":"Contempor Clin Trials"},{"key":"2025042412212670400_pkaf035-B28","doi-asserted-by":"crossref","first-page":"100826","DOI":"10.1016\/j.ssmph.2021.100826","article-title":"Living alone as a risk factor for cancer incidence, case-fatality and all-cause mortality: a nationwide registry study","volume":"15","author":"Elovainio","year":"2021","journal-title":"SSM Popul Health"},{"key":"2025042412212670400_pkaf035-B29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/1049732314543109","article-title":"Living alone during cancer treatment: an exploration of patients\u2019 experiences","volume":"24","author":"Benoot","year":"2014","journal-title":"Qual Health Res"},{"key":"2025042412212670400_pkaf035-B30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/imj.15561","article-title":"Impact of travel distance on outcomes for clinical trial patients: The Kinghorn Cancer Centre experience","volume":"53","author":"Lim","year":"2023","journal-title":"Intern Med J"},{"key":"2025042412212670400_pkaf035-B31","doi-asserted-by":"crossref","first-page":"102046","DOI":"10.1016\/j.esmoop.2023.102046","article-title":"Time toxicity associated with early phase clinical trial participation","volume":"8","author":"Nindra","year":"2023","journal-title":"ESMO Open"},{"key":"2025042412212670400_pkaf035-B32","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.2022.40.16_suppl.1558","article-title":"Impact of trial site selection on minority patient recruitment in prostate cancer trials","volume":"40","author":"Lagor","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025042412212670400_pkaf035-B33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamaoncol.2023.6565","article-title":"Decentralized clinical trials as a new paradigm of trial delivery to improve equity of access","volume":"10","author":"Underhill","year":"2024","journal-title":"JAMA Oncol"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkaf035\/62786183\/pkaf035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/9\/2\/pkaf035\/62786183\/pkaf035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/9\/2\/pkaf035\/62786183\/pkaf035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T16:21:38Z","timestamp":1745511698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkaf035\/8098056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkaf035","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,3]]},"article-number":"pkaf035"}}